Phase I/II study of combination chemotherapy with cisplatin, carboplatin and etoposide in small cell lung cancer

Murray, 1987, The importance of dose and dose intensity in lung cancer chemotherapy, Semin Oncol, 14, 20 Murray, 1991, Intensive weekly chemotherapy for the treatment of extensive stage small cell lung cancer, J Clin Oncol, 9, 1632, 10.1200/JCO.1991.9.9.1632 Ihde, 1994, Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small cell lung cancer, J Clin Oncol, 12, 2022, 10.1200/JCO.1994.12.10.2022 Fukuoka, 1992, Dose intensive weekly chemotherapy with or without recombinant human granulocyte colony-stimulating factor in extensive-stage small-cell lung cancer, 11, 290 Simon, 1990, Selecting drug combinations based on total equivalent dose (dose intensity), J Natl Cancer Inst, 82, 1469, 10.1093/jnci/82.18.1469 Kobayashi, 1992, Combination of cisplatin and carboplatin in vitro and in clinical practice, Cancer chemotherapy, Challenges for the future, 7, 279 Sculier, 1994, Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small cell lung cancer, J Clin Oncol, 12, 353, 10.1200/JCO.1994.12.2.353 Jacobs, 1991, A phase I–II study of cisplatin, carboplatin and etoposide in advanced non-small cell lung cancer, 10, 263 Bunn, 1989, Chemotherapy in small cell lung cancer: a consensus report, Lung Cancer, 5, 9, 10.1016/0169-5002(89)90157-8 Lebeau, 1992, Six vs twelve cycles for complete responders to chemotherapy in small cell lung cancer: definitive results of a randomized clinical trial, Eur Respir J, 5, 286, 10.1183/09031936.93.05030286 Ihde, 1992, Chemotherapy of lung cancer, New Engl J Med, 327, 1434, 10.1056/NEJM199211123272006